Skip to main content

Closed

XERS: Xeris Biopharma Holdings, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

62thpctl

Volume

0.86×avg

Market Cap

1.39BUSD

P/E Ratio

114.1TTM

Div Yield

-ann

Xeris Biopharma Holdings, Inc.

XERSNASDAQ Global Select·USD·Closed

Xeris Biopharma Holdings, Inc.

XERSNASDAQ·USD·Closed

$8.08

−4.04%

$8.08

−$0.34 (4.04%)

52W Range

62thpctl

Volume

0.86×avg

Mkt Cap

1.39BUSD

P/E

114.1TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings